|
TMEM135 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.037400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.812000E-01 |
| Normal-vs-Stage2 |
5.195400E-01 |
| Normal-vs-Stage3 |
9.292500E-02 |
| Normal-vs-Stage4 |
3.869800E-01 |
| Stage1-vs-Stage2 |
3.207000E-01 |
| Stage1-vs-Stage3 |
3.736600E-01 |
| Stage1-vs-Stage4 |
6.572000E-01 |
| Stage2-vs-Stage3 |
9.312000E-02 |
| Stage2-vs-Stage4 |
2.701400E-01 |
| Stage3-vs-Stage4 |
8.920200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.937400E-01 |
| Normal-vs-AfricanAmerican |
3.932800E-01 |
| Normal-vs-Asian |
7.993800E-01 |
| Caucasian-vs-AfricanAmerican |
5.711600E-01 |
| Caucasian-vs-Asian |
9.016400E-01 |
| AfricanAmerican-vs-Asian |
9.395400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.511220E-01 |
| Normal-vs-Female |
3.658200E-01 |
| Male-vs-Female |
7.599800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.233600E-01 |
| Normal-vs-Extreme_Weight |
1.451510E-02 |
| Normal-vs-Obese |
9.175400E-01 |
| Normal-vs-Extreme_Obese |
5.648600E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.290200E-01 |
| Normal_Weight-vs-Obese |
9.042200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.185400E-01 |
| Extreme_Weight-vs-Obese |
1.058560E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.161000E-01 |
| Obese-vs-Extreme_Obese |
6.387400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.091800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.525000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.850170E-01 |
| Normal-vs-Age(81-100Yrs) |
6.704400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.507800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.898000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.913400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.877400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.803800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.461600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.967900E-02 |
| Normal-VS-Type2 PRCC |
2.785000E-01 |
| Normal-VS-KIRP CIMP |
2.899800E-01 |
| Normal-VS-Unclassified PRCC |
9.696200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.890400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.434800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.682400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.412400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.546400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.394200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.058400E-01 |
| Normal-vs-N1 |
2.075600E-01 |
| Normal-vs-N2 |
1.67571999999394E-05 |
| N0-vs-N1 |
3.957000E-01 |
| N0-vs-N2 |
2.45629999999775E-05 |
| N1-vs-N2 |
5.380500E-04 |
|
|
